Displaying One Session

Time
10:30 - 11:30

Welcome and Introductions (ID 4661)

The Role of PD-L1 as a Predictive Biomarker in TNBC (ID 4662)

Tumor agnostic patient management in Immuno-Oncology (ID 4663)

Q&A (ID 4664)

Closing Remarks (ID 4665)